This is consistent with previous findings in HCC suggesting that CD73 promotes tumor progression and metastasis via activating PI3K/AKT signaling by the binding of adenosine to A2A receptor (MA X L, SHEN M N et al. 2019). The gene discussed is NT5E; the disease is neoplasm.